Physiologically Based Pharmacokinetic Modeling to Predict the Pharmacokinetics of Sacubitril/Valsartan in the Elderly with Renal or Hepatic Impairment Population.
Аннотация
This study developed and validated a whole-body physiologically based pharmacokinetic (PBPK) model for sacubitril/valsartan and its active metabolite LBQ657. The model, which incorporates key transporter-mediated clearance pathways, demonstrated robust predictive performance upon validation with clinical data from healthy, renally impaired, and hepatically impaired populations. Simulations using this validated model provided quantitative predictions of steady-state exposure in elderly populations with organ impairment under label-recommended dosing. The results mechanistically confirmed the selective increase in drug exposure driven by organ dysfunction: renal impairment disproportionately elevated LBQ657 exposure, whereas hepatic impairment predominantly increased valsartan exposure. A critical finding was the nuanced interaction between aging and organ impairment, where advanced age selectively exacerbated the exposure of the drug component cleared by the relatively intact organ. This work highlights the potential challenge of balancing exposure for both components when adjusting the dose of this fixed-dose combination in patients with organ dysfunction. The established PBPK model serves as a valuable quantitative tool for informing personalized dosing strategies and supporting clinical decision-making for vulnerable elderly patients with renal or hepatic impairment.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.